Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

First selective ganglioside biosynthesis inhibitors identified at Zacharon Pharma

May 2, 2011

R-507 and R-545 reduce acute cellular rejection in vivo

May 2, 2011

New bivalent immunotoxin shows promise to treat solid tumors

May 2, 2011

CH-4938056 targets microtubule-associated protein 4 to confer antitumor activity

May 2, 2011

AY-4 inhibits tumor growth in model of head and neck cancer

April 29, 2011

Genetic markers of prostate cancer mortality identified in castration-resistant disease

April 29, 2011

Antibody-drug conjugate BAY-94-9343 is active against mesothelin-expressing tumors

April 29, 2011

Second-generation tumor metabolism inhibitor PENAO shows promise in vitro and in vivo

April 29, 2011

TTAC-0001 displays antitumor efficacy in various models

April 29, 2011

AZD-4547 shows preclinical potential to treat solid tumors

April 29, 2011

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...